Harper, C M <br/><br/>
Safety and efficacy of quinidine sulfate in slow-channel congenital myasthenic syndrome.  [electronic resource] 

 -  Annals of the New York Academy of Sciences  May 1998 
 - 203-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0077-8923 
<br/><br/><label>Standard No.: </label>10.1111/j.1749-6632.1998.tb10929.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Child<br/>Humans<br/>Middle Aged<br/>Myasthenia Gravis--drug therapy<br/>Point Mutation<br/>Quinidine--adverse effects<br/>Receptors, Cholinergic--genetics<br/>Syndrome